← Open Payments lookup

HILDER NJOROGE: Open Payments

NPI 1336877596 · LENEXA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,426 in 187 payments from 21 companies in 2025. Trend: 2023 $2,327 · 2024 $2,638 · 2025 $3,426

Food & beverage: $3,291Education: $135
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.17$573
ABBVIE INC.39$535
Otsuka America Pharmaceutical, Inc.25$501
Vanda Pharmaceuticals Inc.18$338
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$290
Supernus Pharmaceuticals, Inc.20$227
E.R. Squibb & Sons, L.L.C.3$144
Axsome Therapeutics, Inc.10$140
Janssen Pharmaceuticals, Inc8$140
Neurocrine BioSciences, Inc.5$106

Products named: VRAYLAR, AUSTEDO XR, REXULTI, CAPLYTA, HETLIOZ, Qelbree, COBENFY, Auvelity.

Industry payments across KS — which companies pay providers there.